Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-17 Sale |
2020-12-21 5:00 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
24,066 | $157.7 | $3,795,233 | 30,883 (Direct) |
View |
| 2020-12-03 Sale |
2020-12-04 4:47 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO |
1,530 | $122.26 | $187,058 | 16,102 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-28 Option Award |
2021-03-02 5:54 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
18,033 | $0 | 64,378 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:52 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO |
24,473 | $0 | 63,940 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:50 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
24,473 | $0 | 88,324 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:48 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
7,616 | $0 | 38,499 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-21 5:00 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
11,000 | $140.16 | 30,883 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-21 5:00 pm |
N/A 2023-06-01 |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
24,066 | $0 | 30,883 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-21 5:00 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
13,066 | $97.58 | 30,883 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:12 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO |
85,592 | $157.96 | 267,773 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:12 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO |
162,707 | $0 | 267,773 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:10 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
8,812 | $157.96 | 30,883 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:10 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
15,371 | $0 | 30,883 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:09 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
21,395 | $157.96 | 67,301 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:09 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
40,677 | $0 | 67,301 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:08 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
19,838 | $157.96 | 46,345 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:08 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
37,965 | $0 | 46,345 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-18 5:06 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
40 | $93.53 | 63,851 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:06 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
21,395 | $157.96 | 63,851 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:06 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
40,677 | $0 | 63,851 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:04 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO |
9,363 | $157.96 | 39,467 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:04 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO |
15,371 | $0 | 39,467 (Direct) |
View |
| 2020-12-16 Tax Withholding |
2020-12-18 5:02 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer |
19,913 | $157.96 | 43,060 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-18 5:02 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer |
56 | $95.53 | 43,060 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:02 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer |
37,965 | $0 | 43,060 (Direct) |
View |
| 2020-12-02 Tax Withholding |
2020-12-04 4:47 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO |
665 | $121.76 | 16,102 (Direct) |
View |
| 2020-11-30 Tax Withholding |
2020-12-01 5:17 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO |
1,298 | $124 | 33,459 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:11 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | ALEXION PHARMACEUTICALS INC. 10% Owner |
9,404,270 | $0 | 1,109,910 (Direct) |
View |
Ownership |
2020-07-23 9:34 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | ALEXION PHARMACEUTICALS INC. 10% Owner |
0 | $0 | 1,109,910 (Direct) |
View |